All submissions should be submitted via this portal: http://mc.manuscriptcentral.com/cbt
Suggested Reviewers
During the submission process, you will be asked to indicate your preferred and non-preferred reviewers, and the reasons for your choices.
Preferred reviewers:
- Should not have a conflict of interest (such as a recent or current close working relationship, or from the same institution)
- At least half of the list should be international to yourself
- Please consider early career researchers as well as field leaders
- Please suggest both niche experts and those with wider knowledge of the subject
Non-preferred reviewers:
- May have personal or subjective bias to your work which disregards the scientific merit
- May have seen or commented on the submitted manuscript, or prior versions.
For more information on the peer review process and to find resources for reviewers, please visit this page.
Supplementary Information – Online only
Where unpublished material e.g. behaviour rating scales or therapy manuals are referred to in an article, copies should be submitted as an additional document (where copyright allows) to facilitate review. Supplementary files can be used to convey supporting or extra information to your study, however, the main manuscript should be able to ‘stand-alone’. Supporting documents are reviewed but not copyedited on acceptance of the article. They can therefore be submitted in PDF format, and include figures and tables within the text. There is no word limit for supporting online information.
Required Statements
Prior to submission, the following statements should be included on the title page:
Acknowledgements
You may acknowledge individuals or organizations that provided advice, support (non-financial).
Conflict of Interest
Authors should include a Conflicts of Interest declaration in their title page. This statement will be published in the final article. Conflicts of Interest are situations that could be perceived to exert an undue influence on an author’s presentation of their work. They may include, but are not limited to, financial, professional, contractual or personal relationships or situations. Conflicts of Interest do not necessarily mean that an author’s work has been compromised. Authors should declare any real or perceived Conflicts of Interest in order to be transparent about the context of their work. If the manuscript has multiple authors, the author submitting the title page must include Conflicts of Interest declarations relevant to all contributing authors. For further information about Conflicts of Interest please see: https://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities--conflicts-of-interest.html.
Example wording for your Conflicts of Interest declaration is as follows: “Conflicts of Interest: Author A is employed at company B. Author C owns shares in company D, is on the Board of company E and is a member of organisation F. Author G has received grants from company H.” If no Conflicts of Interest exist, your declaration should state “Conflicts of Interest: None”.
If the study you are submitting focuses on a commercially available product (such as online CBT tools or APPS) or is funded by a commercial company, you should ensure that your Conflict of Interest statement covers the following:
- What the relationship is between the authors and the company. If authors had access to all study data and if they have entered into any agreement with the company that may limit their independence in analysis and interpretation of the data, preparation of the manuscript and choosing where to publish it.
- What the role of the sponsoring company has been in the following areas: design of the study; data collection, analysis and interpretation; writing the manuscript; approving the manuscript for publication and deciding where to publish.
- Authors should also state that they have not been encouraged or asked to repress, withhold, or modify any data, results, or conclusions by the sponsoring company.
- What influence the connection with the company could be perceived to have and how the authors have mitigated this.
- A statement may also be added by the Editorial Office to clarify what steps the Editors have taken to rule out any bias that may arise from any potential Conflict of Interest.
- Please note internal ethical approval by a commercial company would not be acceptable, it would need to be from an independent institution.
- Any authors with questions regarding this policy are welcome to contact the Editorial Office prior to submission to discuss further.
Data Availability Statement
This is a brief statement about whether the authors of an article have made the evidence supporting their findings available, and if so, where readers may access it. More information on Data Availability Statements and example statements can be found here. Please note that if you are not making your data publicly available, we ask you to state the reason why in your cover letter to the Editor.
Financial support
Please provide details of the sources of financial support for all authors, including grant numbers. For example, "This work was supported by the Medical research Council (grant number XXXXXXX)". Multiple grant numbers should be separated by a comma and space, and where research was funded by more than one agency the different agencies should be separated by a semi-colon, with "and" before the final funder. Grants held by different authors should be identified as belonging to individual authors by the authors’ initials. For example, "This work was supported by the Wellcome Trust (A.B., grant numbers XXXX, YYYY), (C.D., grant number ZZZZ); the Natural Environment Research Council (E.F., grant number FFFF); and the National Institutes of Health (A.B., grant number GGGG), (E.F., grant number HHHH)". Where no specific funding has been provided for research, please provide the following statement: "This research received no specific grant from any funding agency, commercial or not-for-profit sectors."
Licence to publish
Before Cambridge can publish your manuscript, we need a signed licence to publish agreement. Under the agreement, certain rights are granted to the journal owner which allow publication of the article. The original ownership of the copyright in the article remains unchanged. For full details see the publishing agreement page.
ORCID
We encourage authors to identify themselves using ORCID when submitting a manuscript to this journal. ORCID provides a unique identifier for researchers and, through integration with key research workflows such as manuscript submission and grant applications, provides the following benefits:
- Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you have authored.
- Convenience: As more organisations use ORCID, providing your iD or using it to register for services will automatically link activities to your ORCID record, and will enable you to share this information with other systems and platforms you use, saving you re-keying information multiple times.
- Keeping track: Your ORCID record is a neat place to store and (if you choose) share validated information about your research activities and affiliations.
See our ORCID FAQs for more information. If you don’t already have an iD, you can create one by registering directly at https://ORCID.org/register.
ORCIDs can also be used if authors wish to communicate to readers up-to-date information about how they wish to be addressed or referred to (for example, they wish to include pronouns, additional titles, honorifics, name variations, etc.) alongside their published articles. We encourage authors to make use of the ORCID profile’s “Published Name” field for this purpose. This is entirely optional for authors who wish to communicate such information in connection with their article. Please note that this method is not currently recommended for author name changes: see Cambridge’s author name change policy if you want to change your name on an already published article. See our ORCID FAQs for more information.